Iris claw lens insertion useful in aphakic patients

Article

A recent investigation included in Eye has found that performing Artisan iris claw lens insertion is beneficial in acquired aphakia.

A recent investigation included in Eye has found that performing Artisan iris claw lens insertion is beneficial in acquired aphakia.

The study, led by Dr K.S. Lett, Department of Ophthalmology, University Hospitals of Leicester, Leicester, UK, involved a retrospective analysis of 32 aphakic eyes of 31 patients that had experienced Artisan lens implantation. The follow-up varied between 6 and 42 months, with a mean of 17.3 months. Complicated phacoemulsification was the most common cause of aphakia with 17 of the 32 eyes presenting with it.

Best-corrected visual acuity (BCVA) that exceeded preoperative data was gained in 21 of the 32 eyes included in the evaluation. Preoperative BCVA was matched postoperatively in 10 eyes and one eye presented with a BCVA worse than the preoperative data. This was due to non-arteritic anterior ischaemic, optic neuropathy.

Pre-existing glaucoma or ocular hypertension was found in 4 of the total study eyes. There were no problems with intraocular pressure, uveitis, glaucoma or hyphaema during the follow-up period.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.